ClinicalTrials.gov
ClinicalTrials.gov Menu

TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer (DEBIRITUX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01060423
Recruitment Status : Terminated (Terminated due to poor subject enrolment)
First Posted : February 2, 2010
Last Update Posted : October 26, 2016
Sponsor:
Collaborator:
Biocompatibles UK Ltd
Information provided by (Responsible Party):
Hans-Joachim Schmoll, MD, Martin-Luther-Universität Halle-Wittenberg

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2012
  Actual Study Completion Date : May 2015